AU2003297614A1 - Novel activated polyethylene glycol compounds - Google Patents

Novel activated polyethylene glycol compounds

Info

Publication number: AU2003297614A1
Authority: AU; Australia
Prior art keywords: polyethylene glycol; glycol compounds; activated polyethylene; novel activated; novel
Prior art date: 2002-12-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003297614A

Other versions

AU2003297614A8 (en

Inventor

Simeon G. Bowers

Adonis Stassinopoulos

Xue Min Zhou

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cerus Corp

Original Assignee

Cerus Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-04

Filing date

2003-12-03

Publication date

2004-06-23

2003-12-03 Application filed by Cerus Corp filed Critical Cerus Corp

2004-06-23 Publication of AU2003297614A8 publication Critical patent/AU2003297614A8/en

2004-06-23 Publication of AU2003297614A1 publication Critical patent/AU2003297614A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AU2003297614A 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds Abandoned AU2003297614A1 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US43121302P	2002-12-04	2002-12-04
US43121602P	2002-12-04	2002-12-04
US43121502P	2002-12-04	2002-12-04
US43121402P	2002-12-04	2002-12-04
US60/431,216		2002-12-04
US60/431,214		2002-12-04
US60/431,215		2002-12-04
US60/431,213		2002-12-04
PCT/US2003/038262 WO2004050029A2 (en)	2002-12-04	2003-12-03	Novel activated polyethylene glycol compounds

Publications (2)

Publication Number	Publication Date
AU2003297614A8 AU2003297614A8 (en)	2004-06-23
AU2003297614A1 true AU2003297614A1 (en)	2004-06-23

Family

ID=32475715

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU2003298827A Abandoned AU2003298827A1 (en)	2002-12-04	2003-12-03	Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2003297614A Abandoned AU2003297614A1 (en)	2002-12-04	2003-12-03	Novel activated polyethylene glycol compounds
AU2003293237A Abandoned AU2003293237A1 (en)	2002-12-04	2003-12-03	Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003302499A Abandoned AU2003302499A1 (en)	2002-12-04	2003-12-03	Methods for antigen masking of red blood cells resulting in reduced hemolysis

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2003298827A Abandoned AU2003298827A1 (en)	2002-12-04	2003-12-03	Methods for preparing antigen masked red blood cells having reduced hemolysis by sera

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AU2003293237A Abandoned AU2003293237A1 (en)	2002-12-04	2003-12-03	Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003302499A Abandoned AU2003302499A1 (en)	2002-12-04	2003-12-03	Methods for antigen masking of red blood cells resulting in reduced hemolysis

Country Status (2)

Country	Link
AU (4)	AU2003298827A1 (en)
WO (4)	WO2004050848A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521174B2 (en) *	2003-12-05	2009-04-21	Albert Einstein College Of Medicine Of Yeshiva University	Universal red blood cells, methods of preparing same, and uses thereof
CN102108119A (en)	2009-12-25	2011-06-29	天津键凯科技有限公司	Multi-arm polyethylene glycol derivatives and their conjugates and gels with drugs
EA201890149A1 (en)	2015-06-26	2018-07-31	Сирус Корпорейшн	COMPOSITIONS OF CRYOPRECIPLES AND METHODS OF THEIR RECEPTION
US10799533B2 (en)	2015-10-23	2020-10-13	Cerus Corporation	Plasma compositions and methods of use thereof
AU2017382449B2 (en)	2016-12-23	2024-10-24	Cerus Corporation	Systems and methods for testing and screening using compound bound substrates
BR112019018273A2 (en)	2017-03-03	2020-07-14	Cerus Corporation	kits and methods for preparing pathogen inactivated platelet compositions
TWI821233B (en)	2017-12-29	2023-11-11	美商西勒斯股份有限公司	Methods for treating biological fluids, pathogen inactivated biological fluids prepared by the methods, and systems for treating biological fluids
CA3143213A1 (en)	2019-06-22	2020-12-30	Cerus Corporation	Biological fluid treatment systems
WO2020264421A1 (en)	2019-06-28	2020-12-30	Cerus Corporation	System and methods for implementing a biological fluid treatment device
MX2024010825A (en) *	2022-03-07	2024-09-17	Icoat Medical Ab	New use of peg-phospholipid molecules.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL292906A (en) *	1962-10-30
US6312685B1 (en) *	1998-03-13	2001-11-06	Timothy C. Fisher	Red blood cells covalently bound with two different polyethylene glycol derivatives
US20020042043A1 (en) *	2000-05-31	2002-04-11	Adonis Stassinopoulos	Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity

2003
- 2003-12-03 WO PCT/US2003/038224 patent/WO2004050848A2/en not_active Ceased
- 2003-12-03 AU AU2003298827A patent/AU2003298827A1/en not_active Abandoned
- 2003-12-03 WO PCT/US2003/038270 patent/WO2004049914A2/en not_active Ceased
- 2003-12-03 AU AU2003297614A patent/AU2003297614A1/en not_active Abandoned
- 2003-12-03 AU AU2003293237A patent/AU2003293237A1/en not_active Abandoned
- 2003-12-03 AU AU2003302499A patent/AU2003302499A1/en not_active Abandoned
- 2003-12-03 WO PCT/US2003/038262 patent/WO2004050029A2/en not_active Ceased
- 2003-12-03 WO PCT/US2003/038349 patent/WO2004050897A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004050848A2 (en)	2004-06-17
AU2003293237A8 (en)	2004-06-23
WO2004049914A2 (en)	2004-06-17
AU2003293237A1 (en)	2004-06-23
AU2003298827A1 (en)	2004-06-23
AU2003297614A8 (en)	2004-06-23
WO2004050029A3 (en)	2004-10-21
WO2004050029A2 (en)	2004-06-17
AU2003302499A8 (en)	2004-06-23
WO2004050897A3 (en)	2004-08-26
AU2003302499A1 (en)	2004-06-23
AU2003298827A8 (en)	2004-06-23
WO2004049914A3 (en)	2005-02-24
WO2004050897A2 (en)	2004-06-17
WO2004050848A3 (en)	2004-12-09

Publication	Publication Date	Title
AU2003266949A1 (en)	2004-01-19	Compounds
AU2003221098A1 (en)	2003-10-08	Oligofluorenylene compounds
AU2003234732A1 (en)	2003-12-12	Polyethylene blends
AU2003279366A1 (en)	2004-06-07	Novel compounds
AU2003285288A1 (en)	2004-05-04	Composition
AU2003275546A1 (en)	2004-05-04	Heat-schrinkable film
AU2002950744A0 (en)	2002-09-12	Composition
AU2003271626A1 (en)	2004-04-23	Container
AU2003235708A1 (en)	2003-07-30	Polytartrate composition
AU2003226659A1 (en)	2003-10-08	Barrier-protected container
AU2003302904A1 (en)	2004-06-30	Container
AU2003263502A1 (en)	2004-05-04	Storage
AU2003208411A1 (en)	2003-09-04	Anti-glycolytic composition
AU2003297614A1 (en)	2004-06-23	Novel activated polyethylene glycol compounds
AU2003289625A1 (en)	2005-06-17	Collapsible tentpole
AU2003216859A1 (en)	2003-10-08	Amidoacetonitrile compounds
AU2003251259A1 (en)	2004-02-09	Novel compounds
AU2003292667A1 (en)	2004-07-22	Benzocycloheptapyridine compounds
AU2003264792A1 (en)	2004-03-29	Container
AU2003289284A1 (en)	2004-05-13	Container
AU2003229087A1 (en)	2005-01-21	Single-crystal-like materials
AU2003255322A1 (en)	2004-02-23	Compounds
AU2003275480A1 (en)	2004-05-04	Compounds
AU2002950855A0 (en)	2002-09-12	Materials
AU2003277653A1 (en)	2004-06-23	Container

Legal Events

Date	Code	Title	Description
2005-08-25	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase